美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

西北生物療法

0.2598

+0.00883.51%

成交量：243.65萬

成交額：62.37萬

市值：3.90億

市盈率：-2.93

高：0.2647

開：0.2572

低：0.2500

收：0.2510

52周最高：0.4788

52周最低：0.1685

股本：15.02億

流通股本：13.82億

量比：0.71

換手率：0.18%

股息：- -

股息率：- -

每股收益(TTM):-0.0888

每股收益(LYR):-0.0575

淨資產收益率：276.45%

總資產收益率：-141.48%

市淨率：-3.89

市盈率(LYR):-4.52

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

西北生物療法

交易所：

OTCQB

成立時間：

1996

員工人數：

25

公司地址：

4800 Montgomery Lane,Suite 800,Bethesda,Maryland,United States

官網：

http://www.nwbio.com

郵編：

20814

電話：

傳真：

- -

簡介：

Northwest Biotherapeutics, Inc.是一家成立於1996年3月18日，還處於發展階段的生物技術公司。公司同時成立於美國和歐洲（世界上最大的兩個醫療市場），並且還為在德國進行的臨床試驗做準備工作。公司專註於開發比目前治療方法更有效的，治療癌症的免疫治療產品。該產品還無須進行有毒副作用的化療。並且，該公司因為其專有的批量生產技術，擁有成本效益優良的基礎。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/NWBO/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NWBO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NWBO\",,,,,undefined,":{"symbol":"NWBO","market":"US","secType":"STK","nameCN":"西北生物療法","latestPrice":0.2598,"timestamp":1757707200000,"preClose":0.251,"halted":0,"volume":2436454,"delay":15,"floatShares":1381857805,"shares":1501533138,"eps":-0.08878,"marketStatus":"休市中","change":0.0088,"latestTime":"09-12 16:00:00 EDT 延時","open":0.2572,"high":0.2647,"low":0.25,"amount":623684.9161500019,"amplitude":0.058566,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.08878,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1757923200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.251,"volumeRatio":0.7140844078255011},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NWBO\",,,,,undefined,":{"symbol":"NWBO","floatShares":1381857805,"roa":"-141.48%","roe":"276.45%","lyrEps":-0.057517,"volumeRatio":0.7140844078255011,"shares":1501533138,"dividePrice":0,"high":0.2647,"amplitude":0.058566,"preClose":0.251,"low":0.25,"week52Low":0.16845,"pbRate":"-3.89","psRate":"356.58","week52High":0.4788,"institutionHeld":0.001,"latestPrice":0.2598,"eps":-0.08878,"divideRate":0,"volume":2436454,"delay":15,"ttmEps":-0.08878,"open":0.2572,"prevYearClose":0.27475,"prevWeekClose":0.2526,"prevMonthClose":0.301,"prevQuarterClose":0.2399,"fiveDayClose":0.2526,"twentyDayClose":0.2376,"sixtyDayClose":0.2686},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NWBO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-12","symbol":"NWBO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-08-09","symbol":"NWBO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-05-10","symbol":"NWBO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1715313600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-03-05","symbol":"NWBO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1709614800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-11-09","symbol":"NWBO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1699506000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NWBO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NWBO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1342115,"yearFounded":1996,"employeeNum":25,"address":"4800 Montgomery Lane,Suite 800,Bethesda,Maryland,United States","zipCode":"20814","officePhone":"240 497 9024"},"stockCompanyDetail":{"websiteUrl":"http://www.nwbio.com","stockEarnings":[{"period":"1week","weight":-0.0167},{"period":"1month","weight":-0.1296},{"period":"3month","weight":-0.0208},{"period":"6month","weight":-0.2047},{"period":"1year","weight":0.2368},{"period":"ytd","weight":0.1436}],"description":"Northwest Biotherapeutics, Inc.是一家成立於1996年3月18日，還處於發展階段的生物技術公司。公司同時成立於美國和歐洲（世界上最大的兩個醫療市場），並且還為在德國進行的臨床試驗做準備工作。公司專註於開發比目前治療方法更有效的，治療癌症的免疫治療產品。該產品還無須進行有毒副作用的化療。並且，該公司因為其專有的批量生產技術，擁有成本效益優良的基礎。","exchange":"OTCQB","name":"西北生物療法","nameEN":"Northwest Biotherapeutics, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NWBO\",market:\"US\",,,undefined,":null}}